tci Medicare Compliance & Reimbursement - 2006 Issue 5
INDUSTRY NOTES: Generic Statins Could Clinch Significant Part D Savings
Plus: MedPAC's hospital PPS update recommendations receive backlash from AHALow-cost generic statins, which providers use to treat high cholesterol and heart disease, could play a key role in minimizing Part D program costs and maximizing consumer savings. A significant shift from higher-cost statins to lower-cost generics over the next two years could cut statin spending in half, producing $8.2 billion in savings for taxpayers, insurers and Medicare benes, according to a Jan. 11 Consumers Union study."For the Medicare drug benefit to continue without breaking the federal budget, it will be critical that medicines are prescribed based on...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Thank you for choosing Find-A-Code, please Sign In to remove ads.